232 related articles for article (PubMed ID: 16769963)
1. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
Niks EH; Kuks JB; Roep BO; Haasnoot GW; Verduijn W; Ballieux BE; De Baets MH; Vincent A; Verschuuren JJ
Neurology; 2006 Jun; 66(11):1772-4. PubMed ID: 16769963
[TBL] [Abstract][Full Text] [Related]
2. HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5.
Bartoccioni E; Scuderi F; Augugliaro A; Chiatamone Ranieri S; Sauchelli D; Alboino P; Marino M; Evoli A
Neurology; 2009 Jan; 72(2):195-7. PubMed ID: 19139372
[No Abstract] [Full Text] [Related]
3. Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey.
Alahgholi-Hajibehzad M; Yilmaz V; Gülsen-Parman Y; Aysal F; Oflazer P; Deymeer F; Saruhan-Direskeneli G
Hum Immunol; 2013 Dec; 74(12):1633-5. PubMed ID: 23993985
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
5. Anti-MuSK antibodies: correlation with myasthenia gravis severity.
Bartoccioni E; Scuderi F; Minicuci GM; Marino M; Ciaraffa F; Evoli A
Neurology; 2006 Aug; 67(3):505-7. PubMed ID: 16894117
[TBL] [Abstract][Full Text] [Related]
6. High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis.
Nikolic AV; Andric ZP; Simonovic RB; Rakocevic Stojanovic VM; Basta IZ; Bojic SD; Lavrnic DV
Eur J Neurol; 2015 Jan; 22(1):59-63. PubMed ID: 25070808
[TBL] [Abstract][Full Text] [Related]
7. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
8. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
[TBL] [Abstract][Full Text] [Related]
9. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J
Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
[TBL] [Abstract][Full Text] [Related]
10. HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.
Hong Y; Li HF; Romi F; Skeie GO; Gilhus NE
Acta Neurol Scand; 2018 Sep; 138(3):219-226. PubMed ID: 29736936
[TBL] [Abstract][Full Text] [Related]
11. T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients.
Marino M; Maiuri MT; Di Sante G; Scuderi F; La Carpia F; Trakas N; Provenzano C; Zisimopoulou P; Ria F; Tzartos SJ; Evoli A; Bartoccioni E
J Autoimmun; 2014 Aug; 52():113-21. PubMed ID: 24397960
[TBL] [Abstract][Full Text] [Related]
12. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.
Oh SJ; Hatanaka Y; Hemmi S; Young AM; Scheufele ML; Nations SP; Lu L; Claussen GC; Wolfe GI
Muscle Nerve; 2006 Apr; 33(4):500-4. PubMed ID: 16392120
[TBL] [Abstract][Full Text] [Related]
13. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A
Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104
[TBL] [Abstract][Full Text] [Related]
14. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
Zhou L; McConville J; Chaudhry V; Adams RN; Skolasky RL; Vincent A; Drachman DB
Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
[TBL] [Abstract][Full Text] [Related]
15. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
16. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
Guptill JT; Sanders DB; Evoli A
Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
[TBL] [Abstract][Full Text] [Related]
17. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
18. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
19. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.
Pasnoor M; Wolfe GI; Nations S; Trivedi J; Barohn RJ; Herbelin L; McVey A; Dimachkie M; Kissel J; Walsh R; Amato A; Mozaffar T; Hungs M; Chui L; Goldstein J; Novella S; Burns T; Phillips L; Claussen G; Young A; Bertorini T; Oh S
Muscle Nerve; 2010 Mar; 41(3):370-4. PubMed ID: 19882635
[TBL] [Abstract][Full Text] [Related]
20. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
Bau V; Hanisch F; Hain B; Zierz S
Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
